NuPathe, Inc. (PATH) Posts Narrower than Expected Loss of 38c/Share

NuPathe, Inc. (NASDAQ: PATH) reported Q4 EPS of ($0.38), $0.12 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on NuPathe, Inc. (PATH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
• Bernstein SocGen on SpaceX' (SPCX) Investor Views and Controversies Ahead of Earnings
• Royal Caribbean Cruises (RCL) PT Raised to $367 at UBS, Estimates Updated